デフォルト表紙
市場調査レポート
商品コード
1385729

世界の乳児用HMO調製粉乳市場:考察と予測 (2029年まで)

Global HMO Infant Formula Market Insights, Forecast to 2029

出版日: | 発行: QYResearch | ページ情報: 英文 111 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
世界の乳児用HMO調製粉乳市場:考察と予測 (2029年まで)
出版日: 2023年11月28日
発行: QYResearch
ページ情報: 英文 111 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、乳児用HMO調製粉乳 (HMO Infant Formula) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 乳児用HMO調製粉乳の製品概要
  • 市場:タイプ別
    • 世界の乳児用HMO調製粉乳の市場規模成長率:タイプ別, 2018 VS 2022 VS 2029
    • 2'-Fucosyllactose (2'-FL)
    • 3-Fucosyllactose (3-FL)
    • Lactose-N-neotetraose (LNnT)
    • 3'-Sialyllactose (3'-SL)
    • 6'-Sialyllactose (6'-SL)
  • 市場:用途別
    • 世界の乳児用HMO調製粉乳の市場規模成長率:用途別, 2018 VS 2022 VS 2029
    • Online Channel
    • Specialty Store
    • Supermarket
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の乳児用HMO調製粉乳売上予測・予想 2018-2029
  • 世界の乳児用HMO調製粉乳の収益:地域別
    • 世界の乳児用HMO調製粉乳の収益:地域別: 2018 VS 2022 VS 2029
    • 世界の乳児用HMO調製粉乳の収益:地域別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の収益:地域別 (2024-2029)
    • 世界の乳児用HMO調製粉乳の収益市場シェア 地域別 (2018-2029)
  • 世界の乳児用HMO調製粉乳売上予測・予想 2018-2029
  • 世界の乳児用HMO調製粉乳の販売:地域別
    • 世界の乳児用HMO調製粉乳の販売:地域別: 2018 VS 2022 VS 2029
    • 世界の乳児用HMO調製粉乳の販売:地域別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の販売:地域別 (2024-2029)
    • 世界の乳児用HMO調製粉乳の販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア(中国を除く)
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合:企業別

  • 世界の乳児用HMO調製粉乳の販売:企業別
    • 世界の乳児用HMO調製粉乳の販売:企業別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の販売市場シェア:企業別 (2018-2023)
    • 世界の上位10・上位5企業: 乳児用HMO調製粉乳 in 2022
  • 世界の乳児用HMO調製粉乳の収益:企業別
    • 世界の乳児用HMO調製粉乳の収益:企業別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の収益市場シェア:企業別 (2018-2023)
    • 世界の上位10・上位5企業: 乳児用HMO調製粉乳の収益 2022
  • 世界の主要企業 乳児用HMO調製粉乳, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界の乳児用HMO調製粉乳の販売価格:企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の乳児用HMO調製粉乳の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 乳児用HMO調製粉乳, 製造拠点分布と本社
  • 世界の主要メーカー 乳児用HMO調製粉乳, 提供製品と用途
  • 世界の主要メーカー 乳児用HMO調製粉乳, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界の乳児用HMO調製粉乳の販売:タイプ別
    • 世界の乳児用HMO調製粉乳の販売実績:タイプ別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の販売予測:タイプ別 (2024-2029)
    • 世界の乳児用HMO調製粉乳の販売市場シェア:タイプ別 (2018-2029)
  • 世界の乳児用HMO調製粉乳 収益:タイプ別
    • 世界の乳児用HMO調製粉乳の収益実績:タイプ別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の収益予測:タイプ別 (2024-2029)
    • 世界の乳児用HMO調製粉乳の収益市場シェア:タイプ別 (2018-2029)
  • 世界の乳児用HMO調製粉乳の価格:タイプ別
    • 世界の乳児用HMO調製粉乳の価格:タイプ別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の価格予測:タイプ別 (2024-2029)

第5章 市場規模:用途別

  • 世界の乳児用HMO調製粉乳の販売:用途別
    • 世界の乳児用HMO調製粉乳の販売実績:用途別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の販売予測:用途別 (2024-2029)
    • 世界の乳児用HMO調製粉乳の販売市場シェア:用途別 (2018-2029)
  • 世界の乳児用HMO調製粉乳の収益:用途別
    • 世界の乳児用HMO調製粉乳の収益実績:用途別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の収益予測:用途別 (2024-2029)
    • 世界の乳児用HMO調製粉乳の収益市場シェア:用途別 (2018-2029)
  • 世界の乳児用HMO調製粉乳の価格:用途別
    • 世界の乳児用HMO調製粉乳の価格:用途別 (2018-2023)
    • 世界の乳児用HMO調製粉乳の価格予測:用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ 乳児用HMO調製粉乳 市場規模:タイプ別
    • 米国・カナダ 乳児用HMO調製粉乳の販売:タイプ別 (2018-2029)
    • 米国・カナダ 乳児用HMO調製粉乳 収益:タイプ別 (2018-2029)
  • 米国・カナダ 乳児用HMO調製粉乳 市場規模:用途別
    • 米国・カナダ 乳児用HMO調製粉乳の販売:用途別 (2018-2029)
    • 米国・カナダ 乳児用HMO調製粉乳の収益:用途別 (2018-2029)
  • 米国・カナダ 乳児用HMO調製粉乳 市場規模:国別
    • 米国・カナダ 乳児用HMO調製粉乳の収益:国別: 2018 VS 2022 VS 2029
    • 米国・カナダ 乳児用HMO調製粉乳の販売:国別 (2018-2029)
    • 米国・カナダ 乳児用HMO調製粉乳の収益:国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州の乳児用HMO調製粉乳 市場規模:タイプ別
    • 欧州の乳児用HMO調製粉乳の販売:タイプ別 (2018-2029)
    • 欧州の乳児用HMO調製粉乳 収益:タイプ別 (2018-2029)
  • 欧州の乳児用HMO調製粉乳 市場規模:用途別
    • 欧州の乳児用HMO調製粉乳の販売:用途別 (2018-2029)
    • 欧州の乳児用HMO調製粉乳の収益:用途別 (2018-2029)
  • 欧州の乳児用HMO調製粉乳 市場規模:国別
    • 欧州の乳児用HMO調製粉乳の収益:国別: 2018 VS 2022 VS 2029
    • 欧州の乳児用HMO調製粉乳の販売:国別 (2018-2029)
    • 欧州の乳児用HMO調製粉乳の収益:国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の乳児用HMO調製粉乳 市場規模
    • 中国の乳児用HMO調製粉乳 売上 (2018-2029)
    • 中国の乳児用HMO調製粉乳 収益 (2018-2029)
  • 中国の乳児用HMO調製粉乳 市場規模:用途別
    • 中国の乳児用HMO調製粉乳の販売:用途別 (2018-2029)
    • 中国の乳児用HMO調製粉乳の収益:用途別 (2018-2029)

第9章 アジア(中国を除く)

  • アジア地域 乳児用HMO調製粉乳 市場規模:タイプ別
    • アジア地域 乳児用HMO調製粉乳の販売:タイプ別 (2018-2029)
    • アジア地域 乳児用HMO調製粉乳 収益:タイプ別 (2018-2029)
  • アジア地域 乳児用HMO調製粉乳 市場規模:用途別
    • アジア地域 乳児用HMO調製粉乳の販売:用途別 (2018-2029)
    • アジア地域 乳児用HMO調製粉乳の収益:用途別 (2018-2029)
  • アジア地域 乳児用HMO調製粉乳の販売:地域別
    • アジア地域 乳児用HMO調製粉乳の収益:地域別: 2018 VS 2022 VS 2029
    • アジア地域 乳児用HMO調製粉乳の収益:地域別 (2018-2029)
    • アジア地域 乳児用HMO調製粉乳の販売:地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳 市場規模:タイプ別
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の販売:タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳 収益:タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳 市場規模:用途別
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の販売:用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の収益:用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の販売:国別
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の収益:国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の収益:国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの乳児用HMO調製粉乳の販売:国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Abbott
  • Nestle
  • Wyeth Nutrition
  • Hoeslandt
  • Friesland Foods
  • Hyproca
  • Aptamil
  • Biostime
  • Mengniu Dairy
  • Yili Group
  • Feihe
  • Junlebao Dairy Group

第12章 業界チェーンと販売チャネルの分析

  • 乳児用HMO調製粉乳 業界チェーン分析
  • 乳児用HMO調製粉乳 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 乳児用HMO調製粉乳 生産形態とプロセス
  • 乳児用HMO調製粉乳 販売およびマーケティング
    • 乳児用HMO調製粉乳 販売チャネルs
    • 乳児用HMO調製粉乳 卸業者
  • 乳児用HMO調製粉乳 顧客

第13章 市場動向

  • 乳児用HMO調製粉乳 業界動向
  • 乳児用HMO調製粉乳 市場の促進要因
  • 乳児用HMO調製粉乳 市場の課題
  • 乳児用HMO調製粉乳 市場の抑制要因

第14章 主な調査結果 世界の乳児用HMO調製粉乳の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global HMO Infant Formula Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of 2'-Fucosyllactose (2'-FL)
  • Table 3. Major Manufacturers of 3-Fucosyllactose (3-FL)
  • Table 4. Major Manufacturers of Lactose-N-neotetraose (LNnT)
  • Table 5. Major Manufacturers of 3'-Sialyllactose (3'-SL)
  • Table 6. Major Manufacturers of 6'-Sialyllactose (6'-SL)
  • Table 7. Global HMO Infant Formula Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 8. Global HMO Infant Formula Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 9. Global HMO Infant Formula Revenue by Region (2018-2023) & (US$ Million)
  • Table 10. Global HMO Infant Formula Revenue by Region (2024-2029) & (US$ Million)
  • Table 11. Global HMO Infant Formula Revenue Market Share by Region (2018-2023)
  • Table 12. Global HMO Infant Formula Revenue Market Share by Region (2024-2029)
  • Table 13. Global HMO Infant Formula Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 14. Global HMO Infant Formula Sales by Region (2018-2023) & (Tons)
  • Table 15. Global HMO Infant Formula Sales by Region (2024-2029) & (Tons)
  • Table 16. Global HMO Infant Formula Sales Market Share by Region (2018-2023)
  • Table 17. Global HMO Infant Formula Sales Market Share by Region (2024-2029)
  • Table 18. Global HMO Infant Formula Sales by Manufacturers (2018-2023) & (Tons)
  • Table 19. Global HMO Infant Formula Sales Share by Manufacturers (2018-2023)
  • Table 20. Global HMO Infant Formula Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 21. Global HMO Infant Formula Revenue Share by Manufacturers (2018-2023)
  • Table 22. Global Key Players of HMO Infant Formula, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 23. HMO Infant Formula Price by Manufacturers 2018-2023 (US$/Ton)
  • Table 24. Global HMO Infant Formula Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 25. Global HMO Infant Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Infant Formula as of 2022)
  • Table 26. Global Key Manufacturers of HMO Infant Formula, Manufacturing Base Distribution and Headquarters
  • Table 27. Global Key Manufacturers of HMO Infant Formula, Product Offered and Application
  • Table 28. Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
  • Table 29. Mergers & Acquisitions, Expansion Plans
  • Table 30. Global HMO Infant Formula Sales by Type (2018-2023) & (Tons)
  • Table 31. Global HMO Infant Formula Sales by Type (2024-2029) & (Tons)
  • Table 32. Global HMO Infant Formula Sales Share by Type (2018-2023)
  • Table 33. Global HMO Infant Formula Sales Share by Type (2024-2029)
  • Table 34. Global HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
  • Table 35. Global HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
  • Table 36. Global HMO Infant Formula Revenue Share by Type (2018-2023)
  • Table 37. Global HMO Infant Formula Revenue Share by Type (2024-2029)
  • Table 38. HMO Infant Formula Price by Type (2018-2023) & (US$/Ton)
  • Table 39. Global HMO Infant Formula Price Forecast by Type (2024-2029) & (US$/Ton)
  • Table 40. Global HMO Infant Formula Sales by Application (2018-2023) & (Tons)
  • Table 41. Global HMO Infant Formula Sales by Application (2024-2029) & (Tons)
  • Table 42. Global HMO Infant Formula Sales Share by Application (2018-2023)
  • Table 43. Global HMO Infant Formula Sales Share by Application (2024-2029)
  • Table 44. Global HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
  • Table 45. Global HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
  • Table 46. Global HMO Infant Formula Revenue Share by Application (2018-2023)
  • Table 47. Global HMO Infant Formula Revenue Share by Application (2024-2029)
  • Table 48. HMO Infant Formula Price by Application (2018-2023) & (US$/Ton)
  • Table 49. Global HMO Infant Formula Price Forecast by Application (2024-2029) & (US$/Ton)
  • Table 50. US & Canada HMO Infant Formula Sales by Type (2018-2023) & (Tons)
  • Table 51. US & Canada HMO Infant Formula Sales by Type (2024-2029) & (Tons)
  • Table 52. US & Canada HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
  • Table 53. US & Canada HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
  • Table 54. US & Canada HMO Infant Formula Sales by Application (2018-2023) & (Tons)
  • Table 55. US & Canada HMO Infant Formula Sales by Application (2024-2029) & (Tons)
  • Table 56. US & Canada HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
  • Table 57. US & Canada HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
  • Table 58. US & Canada HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 59. US & Canada HMO Infant Formula Revenue by Country (2018-2023) & (US$ Million)
  • Table 60. US & Canada HMO Infant Formula Revenue by Country (2024-2029) & (US$ Million)
  • Table 61. US & Canada HMO Infant Formula Sales by Country (2018-2023) & (Tons)
  • Table 62. US & Canada HMO Infant Formula Sales by Country (2024-2029) & (Tons)
  • Table 63. Europe HMO Infant Formula Sales by Type (2018-2023) & (Tons)
  • Table 64. Europe HMO Infant Formula Sales by Type (2024-2029) & (Tons)
  • Table 65. Europe HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
  • Table 66. Europe HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
  • Table 67. Europe HMO Infant Formula Sales by Application (2018-2023) & (Tons)
  • Table 68. Europe HMO Infant Formula Sales by Application (2024-2029) & (Tons)
  • Table 69. Europe HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
  • Table 70. Europe HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
  • Table 71. Europe HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 72. Europe HMO Infant Formula Revenue by Country (2018-2023) & (US$ Million)
  • Table 73. Europe HMO Infant Formula Revenue by Country (2024-2029) & (US$ Million)
  • Table 74. Europe HMO Infant Formula Sales by Country (2018-2023) & (Tons)
  • Table 75. Europe HMO Infant Formula Sales by Country (2024-2029) & (Tons)
  • Table 76. China HMO Infant Formula Sales by Type (2018-2023) & (Tons)
  • Table 77. China HMO Infant Formula Sales by Type (2024-2029) & (Tons)
  • Table 78. China HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
  • Table 79. China HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
  • Table 80. China HMO Infant Formula Sales by Application (2018-2023) & (Tons)
  • Table 81. China HMO Infant Formula Sales by Application (2024-2029) & (Tons)
  • Table 82. China HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
  • Table 83. China HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
  • Table 84. Asia HMO Infant Formula Sales by Type (2018-2023) & (Tons)
  • Table 85. Asia HMO Infant Formula Sales by Type (2024-2029) & (Tons)
  • Table 86. Asia HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
  • Table 87. Asia HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
  • Table 88. Asia HMO Infant Formula Sales by Application (2018-2023) & (Tons)
  • Table 89. Asia HMO Infant Formula Sales by Application (2024-2029) & (Tons)
  • Table 90. Asia HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
  • Table 91. Asia HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
  • Table 92. Asia HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 93. Asia HMO Infant Formula Revenue by Region (2018-2023) & (US$ Million)
  • Table 94. Asia HMO Infant Formula Revenue by Region (2024-2029) & (US$ Million)
  • Table 95. Asia HMO Infant Formula Sales by Region (2018-2023) & (Tons)
  • Table 96. Asia HMO Infant Formula Sales by Region (2024-2029) & (Tons)
  • Table 97. Middle East, Africa and Latin America HMO Infant Formula Sales by Type (2018-2023) & (Tons)
  • Table 98. Middle East, Africa and Latin America HMO Infant Formula Sales by Type (2024-2029) & (Tons)
  • Table 99. Middle East, Africa and Latin America HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
  • Table 100. Middle East, Africa and Latin America HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America HMO Infant Formula Sales by Application (2018-2023) & (Tons)
  • Table 102. Middle East, Africa and Latin America HMO Infant Formula Sales by Application (2024-2029) & (Tons)
  • Table 103. Middle East, Africa and Latin America HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 106. Middle East, Africa and Latin America HMO Infant Formula Revenue by Country (2018-2023) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America HMO Infant Formula Revenue by Country (2024-2029) & (US$ Million)
  • Table 108. Middle East, Africa and Latin America HMO Infant Formula Sales by Country (2018-2023) & (Tons)
  • Table 109. Middle East, Africa and Latin America HMO Infant Formula Sales by Country (2024-2029) & (Tons)
  • Table 110. Abbott Company Information
  • Table 111. Abbott Description and Major Businesses
  • Table 112. Abbott HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 113. Abbott HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Abbott Recent Developments
  • Table 115. Nestle Company Information
  • Table 116. Nestle Description and Major Businesses
  • Table 117. Nestle HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 118. Nestle HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Nestle Recent Developments
  • Table 120. Wyeth Nutrition Company Information
  • Table 121. Wyeth Nutrition Description and Major Businesses
  • Table 122. Wyeth Nutrition HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 123. Wyeth Nutrition HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Wyeth Nutrition Recent Developments
  • Table 125. Hoeslandt Company Information
  • Table 126. Hoeslandt Description and Major Businesses
  • Table 127. Hoeslandt HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 128. Hoeslandt HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Hoeslandt Recent Developments
  • Table 130. Friesland Foods Company Information
  • Table 131. Friesland Foods Description and Major Businesses
  • Table 132. Friesland Foods HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 133. Friesland Foods HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Friesland Foods Recent Developments
  • Table 135. Hyproca Company Information
  • Table 136. Hyproca Description and Major Businesses
  • Table 137. Hyproca HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 138. Hyproca HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Hyproca Recent Developments
  • Table 140. Aptamil Company Information
  • Table 141. Aptamil Description and Major Businesses
  • Table 142. Aptamil HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 143. Aptamil HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. Aptamil Recent Developments
  • Table 145. Biostime Company Information
  • Table 146. Biostime Description and Major Businesses
  • Table 147. Biostime HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 148. Biostime HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Biostime Recent Developments
  • Table 150. Mengniu Dairy Company Information
  • Table 151. Mengniu Dairy Description and Major Businesses
  • Table 152. Mengniu Dairy HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 153. Mengniu Dairy HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. Mengniu Dairy Recent Developments
  • Table 155. Yili Group Company Information
  • Table 156. Yili Group Description and Major Businesses
  • Table 157. Yili Group HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 158. Yili Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Yili Group Recent Developments
  • Table 160. Feihe Company Information
  • Table 161. Feihe Description and Major Businesses
  • Table 162. Feihe HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 163. Feihe HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Feihe Recent Developments
  • Table 165. Junlebao Dairy Group Company Information
  • Table 166. Junlebao Dairy Group Description and Major Businesses
  • Table 167. Junlebao Dairy Group HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 168. Junlebao Dairy Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 169. Junlebao Dairy Group Recent Developments
  • Table 170. Key Raw Materials Lists
  • Table 171. Raw Materials Key Suppliers Lists
  • Table 172. HMO Infant Formula Distributors List
  • Table 173. HMO Infant Formula Customers List
  • Table 174. HMO Infant Formula Market Trends
  • Table 175. HMO Infant Formula Market Drivers
  • Table 176. HMO Infant Formula Market Challenges
  • Table 177. HMO Infant Formula Market Restraints
  • Table 178. Research Programs/Design for This Report
  • Table 179. Key Data Information from Secondary Sources
  • Table 180. Key Data Information from Primary Sources

List of Figures

  • Figure 1. HMO Infant Formula Product Picture
  • Figure 2. Global HMO Infant Formula Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global HMO Infant Formula Market Share by Type in 2022 & 2029
  • Figure 4. 2'-Fucosyllactose (2'-FL) Product Picture
  • Figure 5. 3-Fucosyllactose (3-FL) Product Picture
  • Figure 6. Lactose-N-neotetraose (LNnT) Product Picture
  • Figure 7. 3'-Sialyllactose (3'-SL) Product Picture
  • Figure 8. 6'-Sialyllactose (6'-SL) Product Picture
  • Figure 9. Global HMO Infant Formula Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 10. Global HMO Infant Formula Market Share by Application in 2022 & 2029
  • Figure 11. Online Channel
  • Figure 12. Specialty Store
  • Figure 13. Supermarket
  • Figure 14. Other
  • Figure 15. HMO Infant Formula Report Years Considered
  • Figure 16. Global HMO Infant Formula Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 17. Global HMO Infant Formula Revenue 2018-2029 (US$ Million)
  • Figure 18. Global HMO Infant Formula Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 19. Global HMO Infant Formula Revenue Market Share by Region (2018-2029)
  • Figure 20. Global HMO Infant Formula Sales 2018-2029 ((Tons)
  • Figure 21. Global HMO Infant Formula Sales Market Share by Region (2018-2029)
  • Figure 22. US & Canada HMO Infant Formula Sales YoY (2018-2029) & (Tons)
  • Figure 23. US & Canada HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Europe HMO Infant Formula Sales YoY (2018-2029) & (Tons)
  • Figure 25. Europe HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. China HMO Infant Formula Sales YoY (2018-2029) & (Tons)
  • Figure 27. China HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. Asia (excluding China) HMO Infant Formula Sales YoY (2018-2029) & (Tons)
  • Figure 29. Asia (excluding China) HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. Middle East, Africa and Latin America HMO Infant Formula Sales YoY (2018-2029) & (Tons)
  • Figure 31. Middle East, Africa and Latin America HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
  • Figure 32. The HMO Infant Formula Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 33. The Top 5 and 10 Largest Manufacturers of HMO Infant Formula in the World: Market Share by HMO Infant Formula Revenue in 2022
  • Figure 34. Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 35. Global HMO Infant Formula Sales Market Share by Type (2018-2029)
  • Figure 36. Global HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • Figure 37. Global HMO Infant Formula Sales Market Share by Application (2018-2029)
  • Figure 38. Global HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • Figure 39. US & Canada HMO Infant Formula Sales Market Share by Type (2018-2029)
  • Figure 40. US & Canada HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • Figure 41. US & Canada HMO Infant Formula Sales Market Share by Application (2018-2029)
  • Figure 42. US & Canada HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • Figure 43. US & Canada HMO Infant Formula Revenue Share by Country (2018-2029)
  • Figure 44. US & Canada HMO Infant Formula Sales Share by Country (2018-2029)
  • Figure 45. U.S. HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 46. Canada HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 47. Europe HMO Infant Formula Sales Market Share by Type (2018-2029)
  • Figure 48. Europe HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • Figure 49. Europe HMO Infant Formula Sales Market Share by Application (2018-2029)
  • Figure 50. Europe HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • Figure 51. Europe HMO Infant Formula Revenue Share by Country (2018-2029)
  • Figure 52. Europe HMO Infant Formula Sales Share by Country (2018-2029)
  • Figure 53. Germany HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 54. France HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 55. U.K. HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 56. Italy HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 57. Russia HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 58. China HMO Infant Formula Sales Market Share by Type (2018-2029)
  • Figure 59. China HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • Figure 60. China HMO Infant Formula Sales Market Share by Application (2018-2029)
  • Figure 61. China HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • Figure 62. Asia HMO Infant Formula Sales Market Share by Type (2018-2029)
  • Figure 63. Asia HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • Figure 64. Asia HMO Infant Formula Sales Market Share by Application (2018-2029)
  • Figure 65. Asia HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • Figure 66. Asia HMO Infant Formula Revenue Share by Region (2018-2029)
  • Figure 67. Asia HMO Infant Formula Sales Share by Region (2018-2029)
  • Figure 68. Japan HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 69. South Korea HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 70. China Taiwan HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 71. Southeast Asia HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 72. India HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 73. Middle East, Africa and Latin America HMO Infant Formula Sales Market Share by Type (2018-2029)
  • Figure 74. Middle East, Africa and Latin America HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • Figure 75. Middle East, Africa and Latin America HMO Infant Formula Sales Market Share by Application (2018-2029)
  • Figure 76. Middle East, Africa and Latin America HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • Figure 77. Middle East, Africa and Latin America HMO Infant Formula Revenue Share by Country (2018-2029)
  • Figure 78. Middle East, Africa and Latin America HMO Infant Formula Sales Share by Country (2018-2029)
  • Figure 79. Brazil HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 80. Mexico HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 81. Turkey HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 82. Israel HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 83. GCC Countries HMO Infant Formula Revenue (2018-2029) & (US$ Million)
  • Figure 84. HMO Infant Formula Value Chain
  • Figure 85. HMO Infant Formula Production Process
  • Figure 86. Channels of Distribution
  • Figure 87. Distributors Profiles
  • Figure 88. Bottom-up and Top-down Approaches for This Report
  • Figure 89. Data Triangulation
  • Figure 90. Key Executives Interviewed
目次

This research report focuses on the HMO Infant Formula Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 HMO Infant Formula Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global HMO Infant Formula Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 2'-Fucosyllactose (2'-FL)
    • 1.2.3 3-Fucosyllactose (3-FL)
    • 1.2.4 Lactose-N-neotetraose (LNnT)
    • 1.2.5 3'-Sialyllactose (3'-SL)
    • 1.2.6 6'-Sialyllactose (6'-SL)
  • 1.3 Market by Application
    • 1.3.1 Global HMO Infant Formula Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Online Channel
    • 1.3.3 Specialty Store
    • 1.3.4 Supermarket
    • 1.3.5 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global HMO Infant Formula Sales Estimates and Forecasts 2018-2029
  • 2.2 Global HMO Infant Formula Revenue by Region
    • 2.2.1 Global HMO Infant Formula Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global HMO Infant Formula Revenue by Region (2018-2023)
    • 2.2.3 Global HMO Infant Formula Revenue by Region (2024-2029)
    • 2.2.4 Global HMO Infant Formula Revenue Market Share by Region (2018-2029)
  • 2.3 Global HMO Infant Formula Sales Estimates and Forecasts 2018-2029
  • 2.4 Global HMO Infant Formula Sales by Region
    • 2.4.1 Global HMO Infant Formula Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global HMO Infant Formula Sales by Region (2018-2023)
    • 2.4.3 Global HMO Infant Formula Sales by Region (2024-2029)
    • 2.4.4 Global HMO Infant Formula Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global HMO Infant Formula Sales by Manufacturers
    • 3.1.1 Global HMO Infant Formula Sales by Manufacturers (2018-2023)
    • 3.1.2 Global HMO Infant Formula Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of HMO Infant Formula in 2022
  • 3.2 Global HMO Infant Formula Revenue by Manufacturers
    • 3.2.1 Global HMO Infant Formula Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by HMO Infant Formula Revenue in 2022
  • 3.3 Global Key Players of HMO Infant Formula, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global HMO Infant Formula Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of HMO Infant Formula, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of HMO Infant Formula, Product Offered and Application
  • 3.8 Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global HMO Infant Formula Sales by Type
    • 4.1.1 Global HMO Infant Formula Historical Sales by Type (2018-2023)
    • 4.1.2 Global HMO Infant Formula Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global HMO Infant Formula Sales Market Share by Type (2018-2029)
  • 4.2 Global HMO Infant Formula Revenue by Type
    • 4.2.1 Global HMO Infant Formula Historical Revenue by Type (2018-2023)
    • 4.2.2 Global HMO Infant Formula Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global HMO Infant Formula Revenue Market Share by Type (2018-2029)
  • 4.3 Global HMO Infant Formula Price by Type
    • 4.3.1 Global HMO Infant Formula Price by Type (2018-2023)
    • 4.3.2 Global HMO Infant Formula Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global HMO Infant Formula Sales by Application
    • 5.1.1 Global HMO Infant Formula Historical Sales by Application (2018-2023)
    • 5.1.2 Global HMO Infant Formula Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global HMO Infant Formula Sales Market Share by Application (2018-2029)
  • 5.2 Global HMO Infant Formula Revenue by Application
    • 5.2.1 Global HMO Infant Formula Historical Revenue by Application (2018-2023)
    • 5.2.2 Global HMO Infant Formula Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global HMO Infant Formula Revenue Market Share by Application (2018-2029)
  • 5.3 Global HMO Infant Formula Price by Application
    • 5.3.1 Global HMO Infant Formula Price by Application (2018-2023)
    • 5.3.2 Global HMO Infant Formula Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada HMO Infant Formula Market Size by Type
    • 6.1.1 US & Canada HMO Infant Formula Sales by Type (2018-2029)
    • 6.1.2 US & Canada HMO Infant Formula Revenue by Type (2018-2029)
  • 6.2 US & Canada HMO Infant Formula Market Size by Application
    • 6.2.1 US & Canada HMO Infant Formula Sales by Application (2018-2029)
    • 6.2.2 US & Canada HMO Infant Formula Revenue by Application (2018-2029)
  • 6.3 US & Canada HMO Infant Formula Market Size by Country
    • 6.3.1 US & Canada HMO Infant Formula Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada HMO Infant Formula Sales by Country (2018-2029)
    • 6.3.3 US & Canada HMO Infant Formula Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe HMO Infant Formula Market Size by Type
    • 7.1.1 Europe HMO Infant Formula Sales by Type (2018-2029)
    • 7.1.2 Europe HMO Infant Formula Revenue by Type (2018-2029)
  • 7.2 Europe HMO Infant Formula Market Size by Application
    • 7.2.1 Europe HMO Infant Formula Sales by Application (2018-2029)
    • 7.2.2 Europe HMO Infant Formula Revenue by Application (2018-2029)
  • 7.3 Europe HMO Infant Formula Market Size by Country
    • 7.3.1 Europe HMO Infant Formula Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe HMO Infant Formula Sales by Country (2018-2029)
    • 7.3.3 Europe HMO Infant Formula Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China HMO Infant Formula Market Size
    • 8.1.1 China HMO Infant Formula Sales (2018-2029)
    • 8.1.2 China HMO Infant Formula Revenue (2018-2029)
  • 8.2 China HMO Infant Formula Market Size by Application
    • 8.2.1 China HMO Infant Formula Sales by Application (2018-2029)
    • 8.2.2 China HMO Infant Formula Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia HMO Infant Formula Market Size by Type
    • 9.1.1 Asia HMO Infant Formula Sales by Type (2018-2029)
    • 9.1.2 Asia HMO Infant Formula Revenue by Type (2018-2029)
  • 9.2 Asia HMO Infant Formula Market Size by Application
    • 9.2.1 Asia HMO Infant Formula Sales by Application (2018-2029)
    • 9.2.2 Asia HMO Infant Formula Revenue by Application (2018-2029)
  • 9.3 Asia HMO Infant Formula Sales by Region
    • 9.3.1 Asia HMO Infant Formula Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia HMO Infant Formula Revenue by Region (2018-2029)
    • 9.3.3 Asia HMO Infant Formula Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America HMO Infant Formula Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America HMO Infant Formula Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America HMO Infant Formula Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America HMO Infant Formula Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America HMO Infant Formula Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America HMO Infant Formula Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America HMO Infant Formula Sales by Country
    • 10.3.1 Middle East, Africa and Latin America HMO Infant Formula Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America HMO Infant Formula Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America HMO Infant Formula Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Information
    • 11.1.2 Abbott Overview
    • 11.1.3 Abbott HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Abbott HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Abbott Recent Developments
  • 11.2 Nestle
    • 11.2.1 Nestle Company Information
    • 11.2.2 Nestle Overview
    • 11.2.3 Nestle HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Nestle HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Nestle Recent Developments
  • 11.3 Wyeth Nutrition
    • 11.3.1 Wyeth Nutrition Company Information
    • 11.3.2 Wyeth Nutrition Overview
    • 11.3.3 Wyeth Nutrition HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Wyeth Nutrition HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Wyeth Nutrition Recent Developments
  • 11.4 Hoeslandt
    • 11.4.1 Hoeslandt Company Information
    • 11.4.2 Hoeslandt Overview
    • 11.4.3 Hoeslandt HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Hoeslandt HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Hoeslandt Recent Developments
  • 11.5 Friesland Foods
    • 11.5.1 Friesland Foods Company Information
    • 11.5.2 Friesland Foods Overview
    • 11.5.3 Friesland Foods HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Friesland Foods HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Friesland Foods Recent Developments
  • 11.6 Hyproca
    • 11.6.1 Hyproca Company Information
    • 11.6.2 Hyproca Overview
    • 11.6.3 Hyproca HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Hyproca HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Hyproca Recent Developments
  • 11.7 Aptamil
    • 11.7.1 Aptamil Company Information
    • 11.7.2 Aptamil Overview
    • 11.7.3 Aptamil HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Aptamil HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Aptamil Recent Developments
  • 11.8 Biostime
    • 11.8.1 Biostime Company Information
    • 11.8.2 Biostime Overview
    • 11.8.3 Biostime HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Biostime HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Biostime Recent Developments
  • 11.9 Mengniu Dairy
    • 11.9.1 Mengniu Dairy Company Information
    • 11.9.2 Mengniu Dairy Overview
    • 11.9.3 Mengniu Dairy HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Mengniu Dairy HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Mengniu Dairy Recent Developments
  • 11.10 Yili Group
    • 11.10.1 Yili Group Company Information
    • 11.10.2 Yili Group Overview
    • 11.10.3 Yili Group HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Yili Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Yili Group Recent Developments
  • 11.11 Feihe
    • 11.11.1 Feihe Company Information
    • 11.11.2 Feihe Overview
    • 11.11.3 Feihe HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Feihe HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Feihe Recent Developments
  • 11.12 Junlebao Dairy Group
    • 11.12.1 Junlebao Dairy Group Company Information
    • 11.12.2 Junlebao Dairy Group Overview
    • 11.12.3 Junlebao Dairy Group HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Junlebao Dairy Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Junlebao Dairy Group Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 HMO Infant Formula Industry Chain Analysis
  • 12.2 HMO Infant Formula Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 HMO Infant Formula Production Mode & Process
  • 12.4 HMO Infant Formula Sales and Marketing
    • 12.4.1 HMO Infant Formula Sales Channels
    • 12.4.2 HMO Infant Formula Distributors
  • 12.5 HMO Infant Formula Customers

13 Market Dynamics

  • 13.1 HMO Infant Formula Industry Trends
  • 13.2 HMO Infant Formula Market Drivers
  • 13.3 HMO Infant Formula Market Challenges
  • 13.4 HMO Infant Formula Market Restraints

14 Key Findings in The Global HMO Infant Formula Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer